Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE)

Journal of Clinical Psychiatry

Volumn 70, Issue 2, 2009, Pages 232-237

  Rasmussen, Keith G ^a   Mueller, Martina ^b   Rummans, Teresa A ^a   Husain, Mustafa M ^c   Petrides, Georgios ^d   Knapp, Rebecca G ^b   Fink, Max ^e   Sampson, Shirlene M ^a   Bailine, Samuel H ^e   Kellner, Charles H ^d  

^a MAYO CLINIC   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM CARBONATE; NORTRIPTYLINE; ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCONVULSIVE THERAPY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; DRUG COMBINATION; DRUG RESISTANCE; FOLLOW UP; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; RECURRENT DISEASE; RISK FACTOR; STATISTICS;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; NORTRIPTYLINE; PERSONALITY INVENTORY; PSYCHOMETRICS; RECURRENCE; RISK FACTORS;

EID: 62649145146     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.08m04092     Document Type: Article

References (25)

1. Rasmussen KG, Mueller M, Kellner CH, et al. Patterns of psychotropic medication use among severely depressed patients referred for ECT: data from the Consortium for Research in ECT. J ECT 2006;22(2):116-123
2. Bruce EM, Crone N, Fitzpatrick G, et al. A comparative trial of ECT and tofranil [letter]. Am J Psychiatry 1960;117:76
3. Pickering G, Bowlby J, Cochrane AL, et al. Clinical trial of the treatment of depressive illness. Br Med J 1965;1:881-886
4. Hamilton M. Drug resistant depressions: response to ECT. Pharmacopsychiatry 1974;7:205-206
5. Prudic J, Sackheim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 1990;31:287-296 (Pubitemid 20102377)
6. Prudic J, Haskett RF, Mulsant B, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 1996; 153(8):985-992 (Pubitemid 26264697)
7. Shapira B, Lindsky D, Gorfine M, et al. Electroconvulsive therapy and resistant depression: clinical implications of seizure threshold. J Clin Psychiatry 1996;57(1):32-38 (Pubitemid 26030526)
8. Tew JD, Mulsant BH, Haskett RF, et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry 1999; 156(12):1865-1870
9. Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000;57:425-434 (Pubitemid 30257256)
10. Dombrovski AY, Mulsant BH, Haskett RF, et al. Predictors of remission after electroconvulsive therapy in unipolar major depression. J Clin Psychiatry 2005;66(10):1043-1049 (Pubitemid 41191798)
11. Bratfos O, Haug JO. Electroconvulsive therapy and antidepressant drugs in manic-depressive disease. Acta Psychiatr Scand 1965;41:588-596
12. Karlinsky H, Shulman KI. The clinical use of electroconvulsive therapy in old age. J Am Geriatr Soc 1984;32:183-186 (Pubitemid 14167903)
13. Magni G, Fisman M, Helmes E. Clinical correlates of ECT-resistant depression in the elderly. J Clin Psychiatry 1988;49(10):405-407 (Pubitemid 18261496)
14. Lam RW, Bartley S, Yatham LN, et al. Clinical predictors of short-term outcome in electroconvulsive therapy. Can J Psychiatry 1999;44: 158-163 (Pubitemid 29173928)
15. Pluijms EM, Birkenhäger TK, Huijbrechts IP, et al. Influence of resistance to antidepressant pharmacotherapy on short-term response to electroconvulsive therapy. J Affect Disord 2002;69:93-99 (Pubitemid 34722875)
16. Husain SS, Kevan IM, Linnell R, et al. Electroconvulsive therapy in depressive illness that has not responded to drug treatment. J Affect Disord 2004;83:121-126 (Pubitemid 39536185)
17. van den Broek WW, de Lely A, Mulder PG, et al. Effect of antidepressant medication resistance on short-term response to electroconvulsive therapy. J Clin Psychopharmacol 2004;24(4):400-403 (Pubitemid 38944138)
18. Rasmussen KG, Mueller M, Knapp RG, et al. Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: a report from the Consortium for Research in Electroconvulsive Therapy. J Clin Psychiatry 2007;68(11):1701-1706 (Pubitemid 350247499)
19. Sackeim HA, Prudic J, Devanand DP, et al. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990;10:96-104 (Pubitemid 20137605)
20. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001;285(10):1299-1307 (Pubitemid 32216144)
21. Rasmussen KG, Knapp RG, Biggs MM, et al. Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the CORE Trial. J ECT 2007;23(4):244-250
22. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P), Version 2.0. New York, NY: Biometrics Research, New York State Psychiatric Institute; 1995
23. Williams JBW. Standardizing the Hamilton Depression Rating Scale: past, present, and future. Eur Arch Psychiatry Clin Neurosci 2001; 251(suppl 2):6-12 (Pubitemid 34020510)
24. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy versus pharmacotherapy for relapse prevention in major depression: a multi-site study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 2006;63(12):1337-1344 (Pubitemid 44878518)
25. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163:1905-1917 (Pubitemid 44807782)